16603352

Source:http://linkedlifedata.com/resource/pubmed/id/16603352

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:16603352	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:16603352	lifeskim:mentions	umls-concept:C0206364	lld:lifeskim
pubmed-article:16603352	lifeskim:mentions	umls-concept:C0038477	lld:lifeskim
pubmed-article:16603352	lifeskim:mentions	umls-concept:C0243077	lld:lifeskim
pubmed-article:16603352	lifeskim:mentions	umls-concept:C1707689	lld:lifeskim
pubmed-article:16603352	pubmed:issue	13	lld:pubmed
pubmed-article:16603352	pubmed:dateCreated	2006-6-1	lld:pubmed
pubmed-article:16603352	pubmed:abstractText	3-Benzimidazol-2-yl-1H-indazole analogs were developed as inhibitors of receptor tyrosine kinases (RTK). The synthesis and SAR of this series is reported.	lld:pubmed
pubmed-article:16603352	pubmed:language	eng	lld:pubmed
pubmed-article:16603352	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16603352	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:16603352	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16603352	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16603352	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16603352	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:16603352	pubmed:month	Jul	lld:pubmed
pubmed-article:16603352	pubmed:issn	0960-894X	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:RenhowePaul...	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:HeiseCarlaC	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:WiesmannMario...	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:JansenJohanna...	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:VoraJayeshJ	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:McBrideChrist...	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:ShaferCynthia...	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:LapointeGenaG	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:MaSylviaS	lld:pubmed
pubmed-article:16603352	pubmed:author	pubmed-author:PiñedaRamonR	lld:pubmed
pubmed-article:16603352	pubmed:issnType	Print	lld:pubmed
pubmed-article:16603352	pubmed:day	1	lld:pubmed
pubmed-article:16603352	pubmed:volume	16	lld:pubmed
pubmed-article:16603352	pubmed:owner	NLM	lld:pubmed
pubmed-article:16603352	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:16603352	pubmed:pagination	3595-9	lld:pubmed
pubmed-article:16603352	pubmed:dateRevised	2009-11-19	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:meshHeading	pubmed-meshheading:16603352...	lld:pubmed
pubmed-article:16603352	pubmed:year	2006	lld:pubmed
pubmed-article:16603352	pubmed:articleTitle	Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.	lld:pubmed
pubmed-article:16603352	pubmed:affiliation	Small Molecule Drug Discovery, Biopharma Division, Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608, USA.	lld:pubmed
pubmed-article:16603352	pubmed:publicationType	Journal Article	lld:pubmed
http://linkedlifedata.com/r...	http://linkedlifedata.com/r...	pubmed-article:16603352	lld:chembl